HIV-1 replication in patients with undetectable plasma virus receiving HAART

Lancet

Volumn 353, Issue 9147, 1999, Pages 119-120

  Natarajan, Ven ^a   Bosche, Marjorie ^a   Metcalf, Julia A ^a   Ward, Douglas J ^a   Lane, H Clifford ^a   Kovacs, Joseph A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; GAG PROTEIN; INTERLEUKIN 2; LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; RNA; STAVUDINE; ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOID TISSUE; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; T LYMPHOCYTE; VIRUS DETECTION; VIRUS REPLICATION;

EID: 0033537355     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)76156-0     Document Type: Article

References (5)

1. 1 Centers for Disease Control and Prevention. Report of the NIH Panel to define principles of therapy of HIV and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR Morb Mortal Wkly Rep 1998; 47: 1-83.
2. 2 Perelson AS, Essunger P, Cao Y, et al. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature 1997; 387: 188-91.
3. 3 Chun TW, Stuyver L, Mizell SB, et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 1997; 94: 13193-97.
4. 4 Kovacs JA, Vogel S, Albert JM, et al. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl J Med 1996; 335: 1350-56.
5. 5 Ho DD. Towards HIV eradication or remission: the tasks ahead. Science 1998; 280: 1866-67.